Physical exercise enhanced heat shock protein 60 expression and attenuated inflammation in the adipose tissue of human diabetic obese

Frontiers in Endocrinology

Volumn 9, Issue FEB, 2018, Pages

  Khadir, Abdelkrim ^a   Kavalakatt, Sina ^a   Cherian, Preethi ^a   Warsame, Samia ^a   Abubaker, Jehad Ahmed ^a   Dehbi, Mohammed ^b   Tiss, Ali ^a  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

^b HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

Author keywords

Adipose tissue; Cellular stress; Heat shock protein 60; Heat shock response; Physical exercise

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; CHAPERONIN 60; CHOLESTEROL; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; CELL STRESS; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DIABETIC OBESITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; GLYCEMIC CONTROL; HEART RATE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 85041832797     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2018.00016     Document Type: Article

References (58)

1. Jaacks LM, Siegel KR, Gujral UP, Narayan KM. Type 2 diabetes: a 21st century epidemic. Best Pract Res Clin Endocrinol Metab (2016) 30:331-43. doi:10.1016/j.beem.2016.05.003
2. Templeman NM, Skovso S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol (2017) 232:R173-83. doi:10.1530/JOE-16-0449
3. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 34:2436-43. doi:10.1093/eurheartj/eht149
4. Dobson R, Burgess MI, Sprung VS, Irwin A, Hamer M, Jones J, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond) (2016) 40:153-61. doi:10.1038/ijo.2015.151
5. Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem (2005) 280:33097-100. doi:10.1074/jbc.R500010200
6. Voellmy R, Boellmann F. Chaperone regulation of the heat shock protein response. Adv Exp Med Biol (2007) 594:89-99. doi:10.1007/978-0-387-39975-1_9
7. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem (2002) 277:15028-34. doi:10.1074/jbc.M200497200
8. Johnson JD, Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J Leukoc Biol (2006) 79:425-34. doi:10.1189/jlb.0905523
9. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes (2002) 51:1102-9. doi:10.2337/diabetes.51.4.1102
10. Kavanagh K, Flynn DM, Jenkins KA, Zhang L, Wagner JD. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys. Am J Physiol Endocrinol Metab (2011) 300:E894-901. doi:10.1152/ajpendo.00699.2010
11. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, et al. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2008) 105:1739-44. doi:10.1073/pnas.0705799105
12. Tiss A, Khadir A, Abubaker J, Abu-Farha M, Al-Khairi I, Cherian P, et al. Immunohistochemical profiling of the heat shock response in obese non-diabetic subjects revealed impaired expression of heat shock proteins in the adipose tissue. Lipids Health Dis (2014) 13:106. doi:10.1186/1476-511X-13-106
13. Cappello F, Marino Gammazza A, Palumbo Piccionello A, Campanella C, Pace A, Conway de Macario E, et al. Hsp60 chaperonopathies and chaperonotherapy: targets and agents. Expert Opin Ther Targets (2014) 18:185-208. doi:10.1517/14728222.2014.856417
14. Kim EY, Durai M, Mia Y, Kim HR, Moudgil KD. Modulation of adjuvant arthritis by cellular and humoral immunity to Hsp65. Front Immunol (2016) 7:203. doi:10.3389/fimmu.2016.00203
15. Grundtman C, Kreutmayer SB, Almanzar G, Wick MC, Wick G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 31:960-8. doi:10.1161/ATVBAHA.110.217877
16. Krause M, Heck TG, Bittencourt A, Scomazzon SP, Newsholme P, Curi R, et al. The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management. Mediators Inflamm (2015) 2015:249205. doi:10.1155/2015/249205
17. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation (2002) 105:1012-7. doi:10.1161/hc0802.103729
18. Gulden E, Marker T, Kriebel J, Kolb-Bachofen V, Burkart V, Habich C. Heat shock protein 60: evidence for receptor-mediated induction of proinflammatory mediators during adipocyte differentiation. FEBS Lett (2009) 583:2877-81. doi:10.1016/j.febslet.2009.07.049
19. Marker T, Kriebel J, Wohlrab U, Habich C. Heat shock protein 60 and adipocytes: characterization of a ligand-receptor interaction. Biochem Biophys Res Commun (2010) 391:1634-40. doi:10.1016/j.bbrc.2009.12.104
20. Calderwood SK, Gong J, Murshid A. Extracellular HSPs: the complicated roles of extracellular HSPs in immunity. Front Immunol (2016) 7:159. doi:10.3389/fimmu.2016.00159
21. Wick G, Jakic B, Buszko M, Wick MC, Grundtman C. The role of heat shock proteins in atherosclerosis. Nat Rev Cardiol (2014) 11:516-29. doi:10.1038/nrcardio.2014.91
22. Selli ME, Wick G, Wraith DC, Newby AC. Autoimmunity to HSP60 during diet induced obesity in mice. Int J Obes (Lond) (2017) 41:348-51. doi:10.1038/ijo.2016.216
23. Pei W, Tanaka K, Huang S, Xu L, Liu B, Sinclair J, et al. Extracellular HSP60 triggers tissue regeneration and wound healing by regulating inflammation and cell proliferation. Regen Med (2016) 1:16013. doi:10.1038/npjregenmed.2016.13
24. Borges TJ, Lang BJ, Lopes RL, Bonorino C. Modulation of alloimmunity by heat shock proteins. Front Immunol (2016) 7:303. doi:10.3389/fimmu.2016.00303
25. Sell H, Poitou C, Habich C, Bouillot JL, Eckel J, Clement K. Heat shock protein 60 in obesity: effect of bariatric surgery and its relation to inflammation and cardiovascular risk. Obesity (Silver Spring) (2017) 25:2108-14. doi:10.1002/oby.22014
26. Voos W, Rottgers K. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta (2002) 1592:51-62. doi:10.1016/S0167-4889(02)00264-1
27. Atalay M, Oksala N, Lappalainen J, Laaksonen DE, Sen CK, Roy S. Heat shock proteins in diabetes and wound healing. Curr Protein Pept Sci (2009) 10:85-95. doi:10.2174/138920309787315202
28. Khadir A, Tiss A, Abubaker J, Abu-Farha M, Al-Khairi I, Cherian P, et al. MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise. Am J Physiol Endocrinol Metab (2015) 308:E71-83. doi:10.1152/ajpendo.00577.2013
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (2001) 25:402-8. doi:10.1006/meth.2001.1262
30. Khadir A, Kavalakatt S, Abubaker J, Cherian P, Madhu D, Al-Khairi I, et al. Physical exercise alleviates ER stress in obese humans through reduction in the expression and release of GRP78 chaperone. Metabolism (2016) 65:1409-20. doi:10.1016/j.metabol.2016.06.004
31. Look ARG, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 369:145-54. doi:10.1056/NEJMoa1212914
32. Gupte AA, Bomhoff GL, Touchberry CD, Geiger PC. Acute heat treatment improves insulin-stimulated glucose uptake in aged skeletal muscle. J Appl Physiol (2011) 110:451-7. doi:10.1152/japplphysiol.00849.2010
33. Rodrigues-Krause J, Krause M, O'Hagan C, De Vito G, Boreham C, Murphy C, et al. Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter? Cell Stress Chaperones (2012) 17:293-302. doi:10.1007/s12192-011-0319-x
34. Marker T, Sell H, Zillessen P, Glode A, Kriebel J, Ouwens DM, et al. Heat shock protein 60 as a mediator of adipose tissue inflammation and insulin resistance. Diabetes (2012) 61:615-25. doi:10.2337/db10-1574
35. Rogers RS, Beaudoin MS, Wheatley JL, Wright DC, Geiger PC. Heat shock proteins: in vivo heat treatments reveal adipose tissue depot-specific effects. J Appl Physiol (1985) (2015) 118:98-106. doi:10.1152/japplphysiol.00286.2014
36. Imatoh T, Sugie T, Miyazaki M, Tanihara S, Baba M, Momose Y, et al. Is heat shock protein 60 associated with type 2 diabetes mellitus? Diabetes Res Clin Pract (2009) 85:208-12. doi:10.1016/j.diabres.2009.06.004
37. Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care (2016) 39(Suppl 2):S244-52. doi:10.2337/dcS15-3015
38. Ye J, McGuinness OP. Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab (2013) 304:E466-77. doi:10.1152/ajpendo.00266.2012
39. Dai X, Zhan J, Demmy TA, Poordad FB, Fauceglia PL, Zhang H, et al. Monocytes play different roles in stimulating T cells in obese diabetic individuals. Int J Immunopathol Pharmacol (2015) 28:374-83. doi:10.1177/0394632015598848
40. Newsholme P, de Bittencourt PI Jr. The fat cell senescence hypothesis: a mechanism responsible for abrogating the resolution of inflammation in chronic disease. Curr Opin Clin Nutr Metab Care (2014) 17:295-305. doi:10.1097/MCO.0000000000000077
41. Quintana FJ, Cohen IR. The HSP60 immune system network. Trends Immunol (2011) 32:89-95. doi:10.1016/j.it.2010.11.001
42. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, et al. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes (2007) 56:1751-60. doi:10.2337/db06-1135
43. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest (2004) 114:1281-9. doi:10.1172/JCI21752
44. Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, Ofrecio JM, et al. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci U S A (2009) 106:18745-50. doi:10.1073/pnas.0903032106
45. Kleinridders A, Lauritzen HP, Ussar S, Christensen JH, Mori MA, Bross P, et al. Leptin regulation of Hsp60 impacts hypothalamic insulin signaling. J Clin Invest (2013) 123:4667-80. doi:10.1172/JCI67615
46. Armstrong MJ, Sigal RJ. Exercise as medicine: key concepts in discussing physical activity with patients who have type 2 diabetes. Can J Diabetes (2015) 39(Suppl 5):S129-33. doi:10.1016/j.jcjd.2015.09.081
47. Zanuso S, Bergamin M, Jimenez A, Pugliese G, D'Errico V, Nicolucci A, et al. Determination of metabolic equivalents during low-and high-intensity resistance exercise in healthy young subjects and patients with type 2 diabetes. Biol Sport (2016) 33:77-82. doi:10.5604/20831862.1194124
48. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes (2000) 49:2102-7. doi:10.2337/diabetes.49.12.2102
49. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature (2006) 440:944-8. doi:10.1038/nature04634
50. van Tienen FH, van der Kallen CJ, Lindsey PJ, Wanders RJ, van Greevenbroek MM, Smeets HJ. Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int J Obes (Lond) (2011) 35:1154-64. doi:10.1038/ijo.2010.275
51. Moldoveanu AI, Shephard RJ, Shek PN. Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. J Appl Physiol (1985) (2000) 89:1499-504. doi:10.1152/jappl.2000.89.4.1499
52. Johannsen NM, Swift DL, Johnson WD, Dixit VD, Earnest CP, Blair SN, et al. Effect of different doses of aerobic exercise on total white blood cell (WBC) and WBC subfraction number in postmenopausal women: results from DREW. PLoS One (2012) 7:e31319. doi:10.1371/journal.pone.0031319
53. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature (2013) 496:445-55. doi:10.1038/nature12034
54. Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes (2015) 64:2289-98. doi:10.2337/db14-1820
55. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Garcia F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord (2013) 13:47. doi:10.1186/1472-6823-13-47
56. Lee CH, Shih AZ, Woo YC, Fong CH, Leung OY, Janus E, et al. Optimal cut-Offs of homeostasis model assessment of insulin resistance (HOMA-IR) to identify dysglycemia and type 2 diabetes mellitus: a 15-year prospective study in Chinese. PLoS One (2016) 11:e0163424. doi:10.1371/journal.pone.0163424
57. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA. Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people. J Clin Endocrinol Metab (2006) 91:629-34. doi:10.1210/jc.2005-1803
58. Gallagher D, Kelley DE, Yim JE, Spence N, Albu J, Boxt L, et al. Group MRIASGotLAR: adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr (2009) 89:807-14. doi:10.3945/ajcn.2008.26955